Target intelligence / Profile preview

Intestinal fluid retention in the gut lumen

Molecular classification
Other
01

Overview

Intestinal fluid retention in the gut lumen is a physiological state characterized by the accumulation of water and electrolytes within the intestinal cavity. It is not a discrete molecular target, such as a receptor or enzyme, but rather a complex biological process regulated by the coordinated activity of various ion transporters and channels, including the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), Sodium-Hydrogen Exchanger 3 (NHE3), and Guanylate Cyclase-C (GC-C) (Barrett, K. E., Gastrointestinal Physiology, 2014). In clinical practice, inducing fluid retention is a therapeutic goal for treating conditions like chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C), as increased luminal volume softens stool and promotes peristalsis (Lacy et al., Therapeutic Advances in Gastroenterology, 2008). Conversely, pathological fluid retention is the primary mechanism of secretory diarrhea, often triggered by bacterial toxins that overactivate secretory pathways (Lembo et al., American Journal of Gastroenterology, 2011). Pharmacological agents such as linaclotide, plecanatide, and tenapanor target specific proteins to modulate this fluid balance for therapeutic effect (Spencer et al., Drugs, 2014).

Other names
Intestinal fluid secretionLuminal fluid accumulationEnteropoolingIntestinal water retention
02

Mechanism of action

Inducing fluid retention via activation of chloride channels (e.g., CFTR, ClC-2), inhibition of sodium absorption (e.g., NHE3), or osmotic draw of water into the lumen.

03

Biological functions

Fluid homeostasisOsmoregulationDigestionStool softeningIntestinal transit regulation
04

Disease associations

Chronic idiopathic constipationIrritable bowel syndrome with constipation (IBS-C)Secretory diarrheaOpioid-induced constipation
05

Safety considerations

DehydrationElectrolyte imbalance (hypokalemia, hyponatremia)Severe diarrheaAbdominal distension
06

Interacting drugs

Linaclotide

5 more in the full profile.

07

Biomarkers

Bristol Stool Scale scoreSpontaneous bowel movement (SBM) frequencyOro-anal transit timeStool water content

Beyond the preview

Go deeper on Intestinal fluid retention in the gut lumen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal fluid retention in the gut lumen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call